Renovacor, Inc.

NYSEAM:RCOR Stock Report

Market Cap: US$53.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Renovacor Management

Management criteria checks 0/4

Key information

Magdalene Cook

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage16.03%
CEO tenure1.2yrs
CEO ownership2.7%
Management average tenure1.2yrs
Board average tenure1.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Magdalene Cook's remuneration changed compared to Renovacor's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-US$13m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$2mUS$338k

-US$14m

Sep 30 2021n/an/a

-US$14m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$4m

Dec 31 2020US$328kUS$218k

-US$3m

Dec 31 2019US$81kUS$77k

-US$2m

Compensation vs Market: Magdalene's total compensation ($USD2.11M) is above average for companies of similar size in the US market ($USD749.50K).

Compensation vs Earnings: Magdalene's compensation has increased whilst the company is unprofitable.


CEO

Magdalene Cook

1.2yrs
Tenure
US$2,107,731
Compensation

Dr. Magdalene K. Cook, MD is President, CEO and Chairman at Renovacor, Inc. since September 2021. Dr. Cook serves as the Principal of Aisling Capital, Aisling Capital II, L.P., Aisling Capital III, L.P. an...


Leadership Team

NamePositionTenureCompensationOwnership
Magdalene Cook
Chairman1.2yrsUS$2.11m2.69%
$ 1.4m
Matthew Killeen
Chief Scientific Officer1.2yrsUS$1.41m0%
$ 0
Marc Semigran
Chief Medical Officer1.2yrsUS$2.27m0%
$ 0
Arthur Feldman
Founder & Member of Scientific Advisory Boardno dataUS$100.00k5.99%
$ 3.2m
Wendy DiCicco
CFO & Principal Financial Officerless than a yearno data0%
$ 0
Elizabeth White
Chief Business Officer & Senior VP of Operations1.3yrsno datano data
Joseph Carroll
Senior VPless than a yearno data0%
$ 0
Jiwen Zhang
Chief Regulatory Officer1.3yrsno datano data
Jordan Shin
Senior Vice President of Clinical Development & Translational Science1.2yrsno datano data
Kumar Dhanasekharan
Senior Vice President of Technical Operations1.1yrsno datano data
Valerie Myers
Senior Director of Preclinical Developmentno datano datano data
1.2yrs
Average Tenure
55yo
Average Age

Experienced Management: RCOR's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Magdalene Cook
Chairman1.2yrsUS$2.11m2.69%
$ 1.4m
Arthur Feldman
Founder & Member of Scientific Advisory Boardno dataUS$100.00k5.99%
$ 3.2m
Michael Bristow
Member of Scientific Advisory Boardno datano datano data
Gregory Covino
Lead Independent Director1.2yrsUS$143.58k0%
$ 0
Thomas Needham
Independent Director1.2yrsUS$139.96k0%
$ 0
Edward Benz
Independent Director1.2yrsUS$162.31k0%
$ 0
Douglas Mann
Member of Scientific Advisory Boardno datano datano data
Gbolahan Amusa Benz
Independent Director4.4yrsUS$139.47k1.66%
$ 891.5k
Joseph Glorioso
Member of Scientific Advisory Boardno datano datano data
Jonas Sven Grossman
Independent Director4.4yrsUS$142.76k2.35%
$ 1.3m
Joan Lau
Independent Director1.2yrsUS$138.32k0%
$ 0
Dennis McNamara
Member of Scientific Advisory Boardno datano datano data
1.2yrs
Average Tenure
56yo
Average Age

Experienced Board: RCOR's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/01 20:56
End of Day Share Price 2022/11/30 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Renovacor, Inc. is covered by 3 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Yun ZhongBTIG
Yevgeniya LivshitsChardan Capital Markets, LLC